Strategic Partnership Pure Source recently formed a manufacturing and supply agreement with Aethl Bio, signaling openness to long-term partnerships and potential co-development opportunities with biotech firms seeking contract manufacturing for creams, lotions, tablets, capsules, and more.

Growth Potential With 51-200 employees and annual revenue between 1M and 10M, Pure Source is positioned for scalable expansions and capacity upgrades, presenting a fit for growth-stage brands looking to ramp production without escalating supplier complexity.

Private Label Focus As a private label contract manufacturer across multiple dosage forms and topicals, Pure Source can capitalize on white-label opportunities for new pharma and consumer health brands seeking outsourcing, customization, and rapid time-to-market.

Technology Enablement Utilizing tools like LiveChat, ZoomInfo, and analytics tracking indicates a digitally enabled sales and customer service approach, suggesting opportunities to engage via targeted outreach, personalized campaigns, and data-driven lead scoring.

Financial Entry Point Moderate revenue scale and a recent high-profile partnership imply readiness for deal-driven engagements, including manufacturing agreements, supply arrangements, and potential entry into longer-term supply contracts with interest in stability and capacity assurance.